510(k) · Cleared
ClearedTarget Detachable Coil
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Stryker Neurovascular · HCG Device, Neurovascular Embolization
Cleared on Dec 11, 2025 as substantially equivalent to K242243 (Stryker Neurovscular, 2024) after a 107-day review. Its family tree reaches back 16 generations to 1995. 1 later device descends from it.
- Decided
- Dec 11, 2025
- Review
- 107 days
- Class
- Class II
- Product code
- HCG
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 16 generations to K951256 (1995). 42 ancestors in all, the oldest K860840 (1986). 1 later device descends from it, 1 citing it directly.
- Root · 16 generations backK951256 Detachable Platinum Coil (Guglielmi Detachable Coil, GDC)Target Therapeutics · 1995
- 12 generations between
- 3 generations backK161429 Target Detachable CoilsStryker Neurovascular · 2016
- 2 generations backK222533 Target Tetra Detachable CoilsStryker Neurovascular · 2022
- 1 generation backK242243 Target Detachable CoilsStryker Neurovscular · 2024
- This deviceK252694 Target Detachable CoilStryker Neurovascular · 2025
- Descendant · cites it directly · 0 of its ownK261772 Target Xtra Detachable CoilStryker Neurovscular · 2026
Show all 16 generations
- Root · 16 generations backK951256 Detachable Platinum Coil (Guglielmi Detachable Coil, GDC)Target Therapeutics · 1995
- 15 generations backK960705 Guglielmi Detachable CoilTarget Therapeutics · 1996
- 14 generations backK962503 Guglielmi Detachable CoilTarget Therapeutics · 1996
- 13 generations backK971395 Guglielmi Detachable Coil (GDC), Fibered Platinum Coil, .035 Type…Target Therapeutics · 1997
- 12 generations backK991139 Guglielmi Detachable (GDC)Boston Scientific, Target · 1999
- 11 generations backK042539 GDC-10 360 Degree Coil SR; GDC-10 360 Degree Soft Coil SR; GDC-18…Boston Scientific Corp · 2004 · Recalled
- 10 generations backK050700 Matrix Stretch Resistant (SR) CoilsBoston Scientific Corp · 2005 · Recalled
- 9 generations backK093142 Target Detachable Coils and Inzone Detachment SystemBoston Scientific Corp · 2010
- 8 generations backK102672 Target Detachable CoilBoston Scientific Corp · 2010
- 7 generations backK112385 Traget Detachable CoilStryker Neurovascular · 2011
- 6 generations backK113412 Target Detachable CoilStryker Neurovascular · 2011 · Recalled
- 5 generations backK123377 Target Detachable CoilStryker Neurovascular · 2012
- 4 generations backK153658 Target Detachable CoilsStryker Neurovascular · 2016 · Recalled
- 3 generations backK161429 Target Detachable CoilsStryker Neurovascular · 2016
- 2 generations backK222533 Target Tetra Detachable CoilsStryker Neurovascular · 2022
- 1 generation backK242243 Target Detachable CoilsStryker Neurovscular · 2024
- This deviceK252694 Target Detachable CoilStryker Neurovascular · 2025
Most influential descendants
Showing 1 of 1 · See all- K261772Target Xtra Detachable CoilStryker Neurovscular · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −16 | K951256 | Detachable Platinum Coil (Guglielmi Detachable Coil, GDC) | Target Therapeutics | 1995 | — |
| −15 | K960705 | Guglielmi Detachable Coil | Target Therapeutics | 1996 | — |
| −14 | K962503 | Guglielmi Detachable Coil | Target Therapeutics | 1996 | — |
| −13 | K971395 | Guglielmi Detachable Coil (GDC), Fibered Platinum Coil, .035 Type, Berenstein… | Target Therapeutics | 1997 | — |
| −12 | K991139 | Guglielmi Detachable (GDC) | Boston Scientific, Target | 1999 | — |
| −11 | K042539 | GDC-10 360 Degree Coil SR; GDC-10 360 Degree Soft Coil SR; GDC-18 360 Degree… | Boston Scientific Corp | 2004 | 2 |
| −10 | K050700 | Matrix Stretch Resistant (SR) Coils | Boston Scientific Corp | 2005 | 1 |
| −9 | K093142 | Target Detachable Coils and Inzone Detachment System | Boston Scientific Corp | 2010 | — |
| −8 | K102672 | Target Detachable Coil | Boston Scientific Corp | 2010 | — |
| −7 | K112385 | Traget Detachable Coil | Stryker Neurovascular | 2011 | — |
| −6 | K113412 | Target Detachable Coil | Stryker Neurovascular | 2011 | 28 |
| −5 | K123377 | Target Detachable Coil | Stryker Neurovascular | 2012 | — |
| −4 | K153658 | Target Detachable Coils | Stryker Neurovascular | 2016 | 28 |
| −3 | K161429 | Target Detachable Coils | Stryker Neurovascular | 2016 | — |
| −2 | K222533 | Target Tetra Detachable Coils | Stryker Neurovascular | 2022 | — |
| −1 | K242243 | Target Detachable Coils | Stryker Neurovscular | 2024 | — |
| 0 (this device) | K252694 | Target Detachable Coil | Stryker Neurovascular | 2025 | — |
| +1 | K261772 | Target Xtra Detachable Coil | Stryker Neurovscular | 2026 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1986 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 2000 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 3 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in HCG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new HCG device
- #1 K252700 Optima Coil System (Optima Packing Coil System)score 20.6 · 26 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K242243 | Target Detachable CoilsSummary page 5…Special Controls Guidance Document: Vascular and Neurovascular Embolization Devices (issued 29 Dec 2004). Legally Marketed Predicate Device: K242243 (Cleared 29 Aug 2024) Page 1 of 5 Stryker Neurovascular 510(k) Summ… | 2024 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K261772 | Target Xtra Detachable Coil | 2026 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 30 years and passes through 5 companies; a new generation was cleared every 12 months on median.
- 9 of the 42 ancestors have a recall of any class.
- Of its descendants, K261772 (Stryker Neurovscular, 2026) has gone furthest, with 0 descendants of its own.
How does its category compare?
All HCG devicesHCG Device, Neurovascular Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.
FDA decisions per year · HCG
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · HCG
107in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · HCG
1in 2025
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · HCG
537in 2025
MAUDE reports naming product code HCG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 8 | 50 | 1 | 326 |
| 2008 | 9 | 71 | 3 | 730 |
| 2009 | 7 | 48 | 0 | 821 |
| 2010 | 8 | 72 | 2 | 851 |
| 2011 | 9 | 78 | 1 | 894 |
| 2012 | 7 | 30 | 0 | 1,146 |
| 2013 | 7 | 67 | 2 | 1,103 |
| 2014 | 5 | 66 | 4 | 1,729 |
| 2015 | 5 | 60 | 0 | 1,598 |
| 2016 | 7 | 37 | 0 | 1,991 |
| 2017 | 5 | 97 | 0 | 2,494 |
| 2018 | 4 | 173 | 0 | 2,058 |
| 2019 | 1 | — | 0 | 1,763 |
| 2020 | 2 | — | 0 | 1,754 |
| 2021 | 5 | 103 | 0 | 2,268 |
| 2022 | 3 | 114 | 2 | 663 |
| 2023 | 2 | — | 0 | 568 |
| 2024 | 4 | 49 | 1 | 552 |
| 2025 | 3 | 107 | 1 (1) | 537 |
| 2026 | 4 | 30 | 1 | — |
What is it indicated for?
Target Detachable Coils are intended to endovascularly obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
Target Detachable Coils are indicated for endovascular embolization of:
• Intracranial aneurysms
• Other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae
• Arterial and venous embolizations in the peripheral vasculature
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K252694 · printed Nov 6, 2026
Cite this page
510(k) Report. “K252694: Target Detachable Coil.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K252694
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026